Nvidia: The Share Price Already Assumes No China Data Center Sales

Nvidia is rated Buy with a $304 price target, implying 33% upside, based on a 19x FY2028 P/E multiple; the stock trades at 14x FY2028 earnings. China data center revenue is excluded from guidance and estimates, while potential approval of the RTX PRO 5500 for China could add $6–$12 per share. The thesis chiefly depends on upcoming Q3 results and Q4 guidance.

Analysis

The key risk is not whether China creates upside, but whether the FY2028 earnings denominator is dependable. A low multiple on distant earnings can be a value trap if accelerator shipments, system-level networking demand, or customer returns on AI capex slow before those earnings arrive. The China estimate is best treated as optionality, not a base-case support: verify the exact product classification, license scope, and whether any approval permits meaningful volume. A workstation GPU approval would not by itself establish a reopening of the broader data-center accelerator market.

Near term, Q3 results and Q4 guidance are the dominant catalysts; any China headline may move the stock but is less informative than order visibility, supply availability, and customer deployment pace. Over 6–18 months, competition from Advanced Micro Devices and customers’ in-house accelerators could pressure pricing or reduce incremental GPU demand, while networking and full-system content may cushion that effect. The contrarian angle is that the apparent discount to the S&P 500 may reflect greater estimate duration and geopolitical risk rather than mispricing. Conversely, if guidance confirms durable demand and the China upside remains excluded, estimates—not just the multiple—could have room to rise. Falsifiers: a Q4 outlook below expectations, evidence of customer digestion, weaker order visibility, or regulatory limits that eliminate the cited China opportunity.

Key Decisions for Investors

• Avoid treating the cited $6–$12 per-share China scenario as dependable value until the license, eligible product, customer demand, and shipment economics are independently verified. Keep it out of the base case.
• For the next few weeks, treat Q3/Q4 guidance as the decision point rather than chasing China-related headlines. If already long, consider reducing event exposure or using a defined-risk hedge; no price data is provided to set an entry or hedge level.
• Add to NVDA only if guidance supports sustained demand and order visibility; the thesis is weakened by a materially softer Q4 outlook, signs of customer digestion, or evidence that in-house alternatives are displacing planned GPU deployments.
• Watch Advanced Micro Devices and customer-developed accelerators as medium-term substitution risks, but do not short them solely on this thesis: the article provides no shipment, pricing, or market-share evidence to establish a near-term relative-value trade.